Pyridine [3,4-b] pyrazinones
US7902195B2 · kind B2 · utility
12Cited by
4References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2007 |
| Grant date | Mar 8, 2011 |
| Priority date | — |
| Expiry date | Aug 29, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I:wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.